Genotoxicity of tobacco smoke-derived aromatic amines and bladder cancer: Current state of knowledge and future research directions

FASEB Journal

Volumn 27, Issue 6, 2013, Pages 2090-2100

  Besaratinia, Ahmad ^a   Tommasi, Stella ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

4 ABP; 4 aminobiphenyl; Carcinogenesis; DNA adducts; Mutation; Tumorigenesis

Indexed keywords

AROMATIC AMINE; CARCINOGEN; TOBACCO SMOKE;

BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENICITY; DNA ADDUCT; DNA REPLICATION; EARLY DIAGNOSIS; GENOTOXICITY; HUMAN; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK FACTOR; RISK REDUCTION; SMOKING; SMOKING CESSATION;

4-ABP; 4-AMINOBIPHENYL; CARCINOGENESIS; DNA ADDUCTS; MUTATION; TUMORIGENESIS;

AMINES; ANIMALS; CARCINOGENS; FEMALE; FORECASTING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MICE; MUTAGENS; RISK FACTORS; SMOKE; SMOKING; URINARY BLADDER NEOPLASMS;

NICOTIANA TABACUM;

EID: 84878749604     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-227074     Document Type: Review

References (93)

1. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., and Forman, D. (2011) Global cancer statistics. CA Cancer J. Clin. 61, 69-900
2. American Cancer Society (2012) Cancer Facts & Figures 2012, American Cancer Society, Atlanta, GA, USA
3. World Health Organization (2008) WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER Package, World Health Organization, Geneva, Switzerland..
4. U.S. Department of Health and Human Services (2004) The Health Consequences of Smoking: A Report of the Surgeon General, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA, USA
5. Boffetta, P. (2008) Tobacco smoking and risk of bladder cancer. Scand J. Urol. Nephrol. Suppl. 42, 45-54
6. Clavel, J., Cordier, S., Boccon-Gibod, L., and Hemon, D. (1989) Tobacco and bladder cancer in males: increased risk for inhalers and smokers of black tobacco. Int. J. Cancer. 44, 605-6100
7. D'Avanzo, B., Negri, E., La Vecchia, C., Gramenzi, A., Bianchi, C., Franceschi, S., and Boyle, P. (1990) Cigarette smoking and bladder cancer. Eur. J. Cancer. 26, 714-7188
8. Vineis, P., Esteve, J., Hartge, P., Hoover, R., Silverman, D. T., and Terracini, B. (1988) Effects of timing and type of tobacco in cigarette-induced bladder cancer. Cancer Res. 48, 3849-38522
9. Patrianakos, C., and Hoffman, D. (1979) Chemical studies on tobacco smoke LXIV. On the analysis of aromatic amines in cigarette smoke. J. Anal. Chem. 150-1544
10. Vineis, P., and Pirastu, R. (1997) Aromatic amines and cancer. Cancer Causes Control 8, 346-3555
11. Bartsch, H., Malaveille, C., Friesen, M., Kadlubar, F. F., and Vineis, P. (1993) Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Eur. J. Cancer. 29A, 1199-12077
12. Luch, A. (2005) Nature and nurture - lessons from chemical carcinogenesis. Nat. Rev. 5, 113-1255
13. Besaratinia, A., and Pfeifer, G. P. (2008) Second-hand smoke and human lung cancer. Lancet Oncol. 9, 657-6666
14. Hecht, S. S. (2008) Progress and challenges in selected areas of tobacco carcinogenesis. Chem. Res. Toxicol. 21, 160-1711
15. Besaratinia, A., and Pfeifer, G. P. (2005) DNA damage and mutagenesis induced by polycyclic aromatic hydrocarbons. In The Carcinogenic Effects of Polycyclic Aromatic Hydrocarbons (Luch, A., ed) pp. 171-210, Imperial College Press, Londonn
16. Poirier, M. C. (2004) Chemical-induced DNA damage and human cancer risk. Nat. Rev. 4, 630-6377
17. Hecht, S. S. (2003) Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat. Rev. 3, 733-7444
18. International Agency for Research on Cancer (1974) 2-Naphthylamine. In Some Aromatic Amines, Hydrazine and Related Substances, N-Nitroso Compounds and Miscellaneous Alkylating Agents pp. 97-111, International Agency for Research on Cancer, Lyon, Francee
19. Parkes, H. G., and Evans, A. E. J. (1984) Epidemiology of aromatic amine cancers. In Chemical Carcinogens, Vol. 1 (Searle, C. E., ed) pp. 277-301, American Chemical Society, Washington DCC
20. Steineck, G., Plato, N., Norell, S. E., and Hogstedt, C. (1990) Urothelial cancer and some industry-related chemicals: an evaluation of the epidemiologic literature. Am. J. Ind. Med. 17, 371-3911
21. Smith, C. J., and Hansch, C. (2000) The relative toxicity of compounds in mainstream cigarette smoke condensate. Food Chem. Toxicol. 38, 637-6466
22. Smith, C. J., Livingston, S. D., and Doolittle, D. J. (1997) An international literature survey of "IARC Group I carcinogens" reported in mainstream cigarette smoke [see comments]. Food Chem. Toxicol. 35, 1107-11300
23. Smith, C. J., Perfetti, T. A., Garg, R., and Hansch, C. (2003) IARC carcinogens reported in cigarette mainstream smoke and their calculated log P values. Food Chem. Toxicol. 41, 807-8177
24. Smith, C. J., Perfetti, T. A., Rumple, M. A., Rodgman, A., and Doolittle, D. J. (2001) "IARC Group 2B carcinogens" reported in cigarette mainstream smoke. Food Chem. Toxicol. 39, 183-2055
25. Besaratinia, A., and Pfeifer, G. P. (2006) Investigating human cancer etiology by DNA lesion footprinting and mutagenicity analysis. Carcinogenesis 27, 1526-15377
26. Pfeifer, G. P., and Besaratinia, A. (2009) Mutational spectra of human cancer. Hum. Genet. 125, 493-5066
27. Petitjean, A., Achatz, M. I., Borresen-Dale, A. L., Hainaut, P., and Olivier, M. (2007) TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 26, 2157-21655
28. Olivier, M., Hollstein, M., and Hainaut, P. (2010) TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harbor Perspect. Biol. 2, a0010088
29. Olivier, M., Hussain, S. P., Caron de Fromentel, C., Hainaut, P., and Harris, C. C. (2004) TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer. IARC Sci. Publ. 157, 247-2700
30. Toyooka, S., Tsuda, T., and Gazdar, A. F. (2003) The TP53 gene, tobacco exposure, and lung cancer. Hum. Mutat. 21, 229-2399
31. Denissenko, M. F., Pao, A., Tang, M., and Pfeifer, G. P. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 274, 430-4322
32. Feng, Z., Hu, W., Chen, J. X., Pao, A., Li, H., Rom, W., Hung, M. C., and Tang, M. S. (2002) Preferential DNA damage and poor repair determine ras gene mutational hotspot in human cancer. J. Natl. Cancer Inst. 94, 1527-15366
33. Hussain, S. P., and Harris, C. C. (1998) Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res. 58, 4023-40377
34. Besaratinia, A., and Pfeifer, G. P. (2009) DNA-lesion mapping in mammalian cells. Methods. 48, 35-399
35. Besaratinia, A., and Pfeifer, G. P. (2012) Measuring the formation and repair of UV damage at the DNA sequence level by ligation-mediated PCR. Methods Mol. Biol. 920, 189-2022
36. Komura, J., and Riggs, A. D. (1998) Terminal transferasedependent PCR: a versatile and sensitive method for in vivo footprinting and detection of DNA adducts. Nucleic Acids Res. 26, 1807-18111
37. Chen, H. H., Kontaraki, J., Bonifer, C., and Riggs, A. D. (2001) Terminal transferase-dependent PCR (TDPCR) for in vivo UV photofootprinting of vertebrate cells. Sci. STKE 2001, PL11
38. Besaratinia, A., Li, H., Yoon, J. I., Zheng, A., Gao, H., and Tommasi, S. (2012) A high-throughput next-generation sequencing- based method for detecting the mutational fingerprint of carcinogens. Nucleic Acids Res. 40, e1166
39. Beland, F. A., and Kadlubar, F. F. (1990) Metabolic activation and DNA adducts of aromatic amines and nitroaromatic hydrocarbons. In Chemical Carcinogenesis and Mutagenesis, Vol. 1 (Cooper , C. S., and Grover, P. L., eds) pp. 297-325, Springer-Verlag, Berlin/Heidelbergg
40. Kadlubar, F. F., Beland, F. A., Beranek, D. T., Dooley, K. L., Heflich, R. H., and Evans, F. E. (1982) Arylamine-DNA adduct formation in relation to urinary bladder carcinogenesis and Salmonella typhimurium mutagenesis. In Environmental Mutagens and Carcinogens (Sugimura, T., Kondo, S., and Takebe, H., eds) pp. 385-396, Alan R. Liss, New Yorkk
41. Talaska, G., al-Juburi, A. Z., and Kadlubar, F. F. (1991) Smokingrelated carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc. Natl. Acad. Sci. U. S. A. 88, 5350-53544
42. McMahon, R. E., Turner, J. C., and Whitaker, G. W. (1980) The N-hydroxylation and ring-hydroxylation of 4-aminobiphenyl in vitro by hepatic mono-oxygenases from rat, mouse, hamster, rabbit and guinea-pig. Xenobiotica 10, 469-4811
43. Kadlubar, F. F., Butler, M. A., Hayes, B. E., Beland, F. A., and Guengerich, F. P. (1988) Role of microsomal cytochromes P-450 and prostaglandin H synthase in 4-aminobiphenyl-DNA adduct formation. In Microsomes and Drug Oxidations (Miners, J., Birkett, D. J., Drew, R., and McManus, M., eds.) pp. 370-379, Taylor and Francis, Londonn
44. Ziegler, D. M., Ansher, S. S., Nagata, T., Kadlubar, F. F., and Jakoby, W. B. (1988) N-methylation: potential mechanism for metabolic activation of carcinogenic primary arylamines. Proc. Natl. Acad. Sci. U. S. A. 85, 2514-25177
45. Chou, H. C., Lang, N. P., and Kadlubar, F. F. (1995) Metabolic activation of the N-hydroxy derivative of the carcinogen 4-aminobiphenyl by human tissue sulfotransferases. Carcinogenesis 16, 413-4177
46. Orzechowski, A., Schrenk, D., Bock-Hennig, B. S., and Bock, K. W. (1994) Glucuronidation of carcinogenic arylamines and their N-hydroxy derivatives by rat and human phenol UDPglucuronosyltransferase of the UGT1 gene complex. Carcinogenesis 15, 1549-15533
47. Poupko, J. M., Hearn, W. L., and Radomski, J. L. (1979) N-Glucuronidation of N-hydroxy aromatic amines: a mechanism for their transport and bladder-specific carcinogenicity. Toxicol. Appl. Pharmacol. 50, 479-4844
48. Frederickson, S. M., Hatcher, J. F., Reznikoff, C. A., and Swaminathan, S. (1992) Acetyl transferase-mediated metabolic activation of N-hydroxy-4-aminobiphenyl by human uroepithelial cells. Carcinogenesis 13, 955-9611
49. Swaminathan, S., and Reznikoff, C. A. (1992) Metabolism and nucleic acid binding of N-hydroxy-4-acetylaminobiphenyl and N-acetoxy-4-acetylaminobiphenyl by cultured human uroepithelial cells. Cancer Res. 52, 3286-32944
50. Besaratinia, A., Bates, S. E., and Pfeifer, G. P. (2002) Mutational signature of the proximate bladder carcinogen N-hydroxy-4- acetylaminobiphenyl: inconsistency with the p53 mutational spectrum in bladder cancer. Cancer Res. 62, 4331-43388
51. Lambert, I. B., Singer, T. M., Boucher, S. E., and Douglas, G. R. (2005) Detailed review of transgenic rodent mutation assays. Mutat. Res. 590, 1-2800
52. Jakubczak, J. L., Merlino, G., French, J. E., Muller, W. J., Paul, B., Adhya, S., and Garges, S. (1996) Analysis of genetic instability during mammary tumor progression using a novel selectionbased assay for in vivo mutations in a bacteriophage lambda transgene target. Proc. Natl. Acad. Sci. U. S. A. 93, 9073-90788
53. Broyde, S., Hingerty, B. E., and Srinivasan, A. R. (1985) Influence of the carcinogen 4-aminobiphenyl on DNA conformation. Carcinogenesis 6, 719-7255
54. Shapiro, R., Underwood, G. R., Zawadzka, H., Broyde, S., and Hingerty, B. E. (1986) Conformation of d(CpG) modified by the carcinogen 4-aminobiphenyl: a combined experimental and theoretical analysis. Biochemistry 25, 2198-22055
55. Drake, J. W., and Baltz, R. H. (1976) The biochemistry of mutagenesis. Annu. Rev. Biochem. 45, 11-377
56. Topal, M. D., and Fresco, J. R. (1976) Complementary base pairing and the origin of substitution mutations. Nature 263, 285-2899
57. Chen, T., Mittelstaedt, R. A., Beland, F. A., Heflich, R. H., Moore, M. M., and Parsons, B. L. (2005) 4-Aminobiphenyl induces liver DNA adducts in both neonatal and adult mice but induces liver mutations only in neonatal mice. Int. J. Cancer. 117, 182-1877
58. Manjanatha, M. G., Li, E. E., Fu, P. P., and Heflich, R. H. (1996) H- and K-ras mutational profiles in chemically induced liver tumors from B6C3F1 and CD-1 mice. J. Toxicol. Environ. Health 47, 195-2088
59. Melchior, W. B., Jr., Marques, M. M., and Beland, F. A. (1994) Mutations induced by aromatic amine DNA adducts in pBR322. Carcinogenesis 15, 889-8999
60. Verghis, S. B., Essigmann, J. M., Kadlubar, F. F., Morningstar, M. L., and Lasko, D. D. (1997) Specificity of mutagenesis by 4-aminobiphenyl: mutations at G residues in bacteriophage M13 DNA and GC transversions at a unique dG(8-ABP) lesion in single-stranded DNA. Carcinogenesis 18, 2403-24144
61. Zayas-Rivera, B., Zhang, L., Grant, S. G., Keohavong, P., and Day, B. W. (2001) Mutational spectrum of N-hydroxy-N-acetyl- 4-aminobiphenyl at exon 3 of the HPRT gene. Biomarker 6, 262-2733
62. Yoon, J. I., Kim, S. I., Tommasi, S., and Besaratinia, A. (2012) Organ specificity of the bladder carcinogen 4-aminobiphenyl in inducing DNA damage and mutation in mice. Cancer Prev. Res. (Phila.) 5, 299-3088
63. Al-Atrash, J., Zhang, Y. J., Lin, D., Kadlubar, F. F., and Santella, R. M. (1995) Quantitative immunohistochemical analysis of 4-aminobiphenyl-DNA in cultured cells and mice: comparison to gas chromatography/mass spectroscopy analysis. Chem. Res. Toxicol. 8, 747-7522
64. Besaratinia, A., Van Straaten, H. W., Kleinjans, J. C., and Van Schooten, F. J. (2000) Immunoperoxidase detection of 4-aminobiphenyl- and polycyclic aromatic hydrocarbons-DNA adducts in induced sputum of smokers and non-smokers. Mutat. Res. 468, 125-1355
65. Curigliano, G., Zhang, Y. J., Wang, L. Y., Flamini, G., Alcini, A., Ratto, C., Giustacchini, M., Alcini, E., Cittadini, A., and Santella, R. M. (1996) Immunohistochemical quantitation of 4-aminobiphenyl- DNA adducts and p53 nuclear overexpression in T1 bladder cancer of smokers and nonsmokers. Carcinogenesis 17, 911-9166
66. Hsu, T. M., Zhang, Y. J., and Santella, R. M. (1997) Immunoperoxidase quantitation of 4-aminobiphenyl- and polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral and urothelial cells of smokers and nonsmokers. Cancer Epidemiol. Biomarkers Prev. 6, 193-1999
67. Faraglia, B., Chen, S. Y., Gammon, M. D., Zhang, Y., Teitelbaum, S. L., Neugut, A. I., Ahsan, H., Garbowski, G. C., Hibshoosh, H., Lin, D., Kadlubar, F. F., and Santella, R. M. (2003) Evaluation of 4-aminobiphenyl-DNA adducts in human breast cancer: the influence of tobacco smoke. Carcinogenesis 24, 719-7255
68. Schieferstein, G. J., Littlefield, N. A., Gaylor, D. W., Sheldon, W. G., and Burger, G. T. (1985) Carcinogenesis of 4-aminobiphenyl in BALB/cStCrlfC3Hf/Nctr mice. Eur. J. Cancer Clin. Oncol. 21, 865-8733
69. Schieferstein, G. J. (1983) Carcinogenesis of 4-aminobiphenyl in mice, National Center for Toxicological Research, Jefferson, AR, USA
70. Besaratinia, A., Kim, S. I., and Pfeifer, G. P. (2008) Rapid repair of UVA-induced oxidized purines and persistence of UVBinduced dipyrimidine lesions determine the mutagenicity of sunlight in mouse cells. FASEB J. 22, 2379-23922
71. Kim, S. I., Yoon, J. I., Tommasi, S., and Besaratinia, A. (2012) New experimental data linking secondhand smoke exposure to lung cancer in nonsmokers. FASEB J. 26, 1845-18544
72. Meyerson, M., Gabriel, S., and Getz, G. (2010) Advances in understanding cancer genomes through second-generation sequencing. Nat. Rev. Genet. 11, 685-6966
73. Bamshad, M. J., Ng, S. B., Bigham, A. W., Tabor, H. K., Emond, M. J., Nickerson, D. A., and Shendure, J. (2011) Exome sequencing as a tool for Mendelian disease gene discovery. Nat. Rev. Genet. 12, 745-7555
74. Choi, M., Scholl, U. I., Ji, W., Liu, T., Tikhonova, I. R., Zumbo, P., Nayir, A., Bakkaloglu, A., Ozen, S., Sanjad, S., Nelson- Williams, C., Farhi, A., Mane, S., and Lifton, R. P. (2009) Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc. Natl. Acad. Sci. U. S. A. 106, 19096-191011
75. Biesecker, L. G. (2010) Exome sequencing makes medical genomics a reality. Nat. Genet. 42, 13-144
76. Ng, S. B., Buckingham, K. J., Lee, C., Bigham, A. W., Tabor, H. K., Dent, K. M., Huff, C. D., Shannon, P. T., Jabs, E. W., Nickerson, D. A., Shendure, J., and Bamshad, M. J. (2010) Exome sequencing identifies the cause of a mendelian disorder. Nat. Genet. 42, 30-355
77. Ng, S. B., Turner, E. H., Robertson, P. D., Flygare, S. D., Bigham, A. W., Lee, C., Shaffer, T., Wong, M., Bhattacharjee, A., Eichler, E. E., Bamshad, M., Nickerson, D. A., and Shendure, J. (2009) Targeted capture and massively parallel sequencing of 12 human exomes. Nature 461, 272-2766
78. Baylin, S. B., and Jones, P. A. (2011) A decade of exploring the cancer epigenome-biological and translational implications. Nat. Rev. 11, 726-7344
79. Esteller, M. (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet. 8, 286-2988
80. Esteller, M. (2008) Epigenetics in cancer. N. Engl. J. Med. 358, 1148-11599
81. Issa, J. P. (2004) CpG island methylator phenotype in cancer. Nat. Rev. 4, 988-9933
82. Jones, P. A., and Baylin, S. B. (2007) The epigenomics of cancer. Cell 128, 683-6922
83. Laird, P. W. (2010) Principles and challenges of genomewide DNA methylation analysis. Nat. Rev. Genet. 11, 191-2033
84. Schembri, F., Sridhar, S., Perdomo, C., Gustafson, A. M., Zhang, X., Ergun, A., Lu, J., Liu, G., Bowers, J., Vaziri, C., Ott, K., Sensinger, K., Collins, J. J., Brody, J. S., Getts, R., Lenburg, M. E., and Spira, A. (2009) MicroRNAs as modulators of smokinginduced gene expression changes in human airway epithelium. Proc. Natl. Acad. Sci. U. S. A. 106, 2319-23244
85. Suzuki, M. M., and Bird, A. (2008) DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet. 9, 465-4766
86. Cortessis, V. K., Thomas, D. C., Levine, A. J., Breton, C. V., Mack, T. M., Siegmund, K. D., Haile, R. W., and Laird, P. W. (2012) Environmental epigenetics: prospects for studying epigenetic mediation of exposure-response relationships. Hum. Genet. 131, 1565-15899
87. Terry, M. B., Delgado-Cruzata, L., Vin-Raviv, N., Wu, H. C., and Santella, R. M. (2011) DNA methylation in white blood cells: association with risk factors in epidemiologic studies. Epigenetics 6, 828-8377
88. Dudziec, E., Goepel, J. R., and Catto, J. W. (2011) Global epigenetic profiling in bladder cancer. Epigenomics 3, 35-455
89. Liu, F., Killian, J. K., Yang, M., Walker, R. L., Hong, J. A., Zhang, M., Davis, S., Zhang, Y., Hussain, M., Xi, S., Rao, M., Meltzer, P. A., and Schrump, D. S. (2010) Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene 29, 3650-36644
90. McConkey, D. J., Lee, S., Choi, W., Tran, M., Majewski, T., Siefker-Radtke, A., Dinney, C., and Czerniak, B. (2010) Molecular genetics of bladder cancer: emerging mechanisms of tumor initiation and progression. Urol. Oncol. 28, 429-4400
91. Netto, G. J. (2012) Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet? Nat. Rev. Urol. 9, 41-511
92. Volanis, D., Papadopoulos, G., Doumas, K., Gkialas, I., and Delakas, D. (2011) Molecular mechanisms in urinary bladder carcinogenesis. J. BUON 16, 589-6011
93. Ru, Y., Dancik, G. M., and Theodorescu, D. (2011) Biomarkers for prognosis and treatment selection in advanced bladder cancer patients. Curr. Opin. Urol. 21, 420-4277